Mubasher: Kamco Invest, listed on Boursa Kuwait, has taken on the role of exclusive sell-side advisor to Egypt’s Al-Tayseer Healthcare Group (THG) in the sale of a minority stake to the private equity fund of Egypt-based private equity firm Ezdehar Management (Ezdehar).
The deal was concluded through the Ezdehar Egypt Mid-Cap Fund in September, with the aim of supporting THG’s efforts in strengthening its position as the top healthcare provider in Egypt’s Delta region, according to a statement on Tuesday.
The fund attracted contributions from several international institutions, including the European Bank for Reconstruction and Development (EBRD), the European Investment Bank (EIB), UK’s CDC Group, and the Dutch Entrepreneurial Development Bank (FMO).
Over the last five years, THG reported robust growth, backed by the expansion of Al-Tayseer International Hospital in Zagazig, in addition to carrying out several investment transactions such as an 80% acquisition in Hassab Labs in 2019 in which Kamco acted as an exclusive buy-side advisor.
Abdullah Al Sharekh, Managing Director of Markets and Investment Banking at Kamco Invest, said, “We are proud to once again successfully assist Al-Tayseer Healthcare Group in concluding a milestone transaction that will diversify its shareholder base and aid the organisation in solidifying its role as a leading hospital group in Egypt’s Delta region.”
Since its establishment, Kamco Invest has served as investment banker to deals worth over $23 billion in equity capital markets, debt capital markets, and mergers and acquisitions (M&A).
It has also provided advisory services on M&A mandates with a value of more than $5.5 billion in various markets and industries.
